Antigen Or Antibody Entrapped Within The Carrier (e.g., Gel, Hollow Fiber, Etc.) Patents (Class 436/535)
-
Patent number: 6271044Abstract: The present invention provides a viscometric method of detecting the presence or absence of an analyte in a solution. The method utilizes a dispersion of a conjugate and a receptor. The conjugate functions as an analog of the analyte, and the receptor can interact with both the analyte and the conjugate to change the viscosity of the dispersion. The test solution is introduced into an aliquot of the dispersion. Equivalent spots of the dispersion and the aliquot containing the analyte within the dispersion are then placed on a substrate such that the spots can spread upon the substrate. The presence of analyte in the test solution is detected by noting a change in the viscosity of the dispersion through a comparison of the spots. To facilitate the method, the invention provides a test kit comprising a conjugate comprising an analog of the analyte, a receptor binding the analog and the analyte, and a substrate upon which spots of liquid can spread.Type: GrantFiled: May 6, 1998Date of Patent: August 7, 2001Assignee: University of Pittsburgh of the Commonwealth System of Higher EducationInventors: Ralph Ballerstadt, Jerome S. Schultz
-
Patent number: 6251691Abstract: A method and apparatus for the manipulation of colloidal particles and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution. Light-controlled electrokinetic assembly of particles near surfaces relies on the combination of three functional elements: the AC electric field-induced assembly of planar aggregates; the patterning of the electrolyte/silicon oxide/silicon interface to exert spatial control over the assembly process; and the real-time control of the assembly process via external illumination. The present invention provides a set of fundamental operations enabling interactive control over the creation and placement of planar arrays of several types of particles and biomolecules and the manipulation of array shape and size. The present invention enables sample preparation and handling for diagnostic assays and biochemical analysis in an array format, and the functional integration of these operations.Type: GrantFiled: October 26, 1998Date of Patent: June 26, 2001Assignee: Bioarray Solutions, LLCInventor: Michael Seul
-
Patent number: 6245578Abstract: An analytical apparatus comprises a biosensor device (3) which forms the base of a sample chamber. A stirrer (8) extends into the sample chamber and moves within the chamber so as to homogenize a sample contained within the chamber in contact with the biosensor (3). Movement of the stirrer (8) is preferably reciprocal movement along an axis perpendicular to the surface of the biosensor (3).Type: GrantFiled: February 23, 1998Date of Patent: June 12, 2001Assignee: Fisons PLCInventor: James Oscar Molloy
-
Patent number: 6238930Abstract: Starting from two non-miscible phases, i.e., a lipophilic and a hydrophilic phase, a surface-active substance and a recognition component, a micellar recognition system is built in a suitable manner and is incorporated into a layer structure. The micellar recognition system is provided in a single thin layer in which the recognition component is distributed homogeneously. Additional layers which may be provided about this layer, have an influence on the properties of the entire layer structure. On contact between the layer structure and the substance to be measured a recognition step takes place in the layer which is followed by a transducing step. In this way a measurement variable is produced by means of which information is obtained on the substance. The layer structures exhibit higher sensitivity, a lower detection threshold, short response time and special robustness with regard to sample interference.Type: GrantFiled: March 8, 1999Date of Patent: May 29, 2001Assignee: AVL Medical Instruments AGInventors: Ursula Spichiger-Keller, Eva Vaillo
-
Patent number: 6224831Abstract: The subject invention relates to a rapid, field-portable, modular, versatile and highly reliable assay device for substances, particularly drugs of abuse, which provides a positive signal in the presence of a specific substance for which the device has been specifically adapted to test. The subject invention also concerns methods for making and using the assay device. The device is easily and reliably manufactured by laminating a series of manufactured layers to each other to form an upper card assembly and a lower card assembly. The upper card assembly is bonded to the upper side of a layer which has an immobilized reagent specific for a test substance bound thereto, and the lower card assembly is bonded to the lower side of the layer having the immobilized reagent. The device can be manufactured and distributed in a unitary, ready-to-use form.Type: GrantFiled: March 31, 1998Date of Patent: May 1, 2001Assignee: John Co., Inc.Inventors: Alan P. Stafford, H. Kevin Smith, David Yarnes
-
Patent number: 6221623Abstract: Primary screening for cervical dysplasia is effected by measuring a biochemical marker of apoptosis and/or angiogenesis in each of a population of cells derived from convenient, superficial swabbing, sponging, scraping or lavage of superficial epithelial cells from the cervix, wherein the marker indicates the presence of cervical dysplasia in the sample, and scoring the results of the measuring step for cervical dysplasia (i.e. ascertaining whether or not the marker is present) in the patient in the absence of any cytological examination.Type: GrantFiled: November 10, 1998Date of Patent: April 24, 2001Assignee: The Regents of the University of CaliforniaInventors: Karen Smith-McCune, Ellen Beth Grossnickle, Nooshin Razani
-
Patent number: 6210910Abstract: A biosensor, sensor array, sensing method and sensing apparatus are provided in which individual cells or randomly mixed populations of cells, having unique response characteristics to chemical and biological materials, are deployed in a plurality of microwells formed at the distal end of individual fibers within a fiber optic array. The biosensor array utilizes an optically interrogatable encoding scheme for determining the identity and location of each cell type in the array and provides for simultaneous measurements of large numbers of individual cell responses to target analytes. The sensing method utilizes the unique ability of cell populations to respond to biologically significant compounds in a characteristic and detectable manner. The biosensor array and measurement method may be employed in the study of biologically active materials, in situ environmental monitoring, monitoring of a variety of bioprocesses, and for high throughput screening of large combinatorial chemical libraries.Type: GrantFiled: March 2, 1998Date of Patent: April 3, 2001Assignee: Trustees of Tufts CollegeInventors: David R. Walt, Laura Taylor
-
Patent number: 6210906Abstract: The present invention provides monoclonal antibodies specific for kringle 5 of apo(a) and hybridomas secreting such antibodies. The invention also relates to assay methods for directly measuring concentrations of lipoprotein(a) [Lp(a)] in a plasma sample. In one embodiment, the method involves the specific capture of Lp(a) from a plasma sample with a monoclonal antibody developed against kringle 5 of apo(a), which is non-cross-reactive with plasminogen and kringle 4 of apo(a). The quantity of the Lp(a) present in the sample is then measured by detecting the amount of Lp(a)-anti-kringle 5 complex that has formed in the reaction. Alternatively, the Lp(a) may be captured non-specifically and then detected with the monoclonal antibody specific for kringle 5 of apo(a). The invention also provides competitive assays using the above-mentioned kringle 5 specific monoclonal antibodies.Type: GrantFiled: January 20, 1999Date of Patent: April 3, 2001Assignee: Abbott LaboratoriesInventors: Samar K. Kundu, Robert N. Ziemann
-
Patent number: 6210909Abstract: A biological fluid collection container comprising a cup member, a lid assembly removably mounted to the cup member comprising a housing with a downwardly extending cylindrical skirt, a luer lock with a throughgoing bore extending from one side of the lid housing. A hollow tube extends from the other side of the lid housing adjacent the luer lock and is axially aligned with the throughgoing bore of the luer lock. The hollow tube is provided with a plurality of throughgoing holes leading into its lumen along its surface to provide for a sampling along various liquid level layers of the biological fluid specimen collected in the cup member so that when the biological fluid specimen is removed from the cup member a representative sampling is obtained.Type: GrantFiled: December 15, 1998Date of Patent: April 3, 2001Assignee: Lamina, Inc.Inventor: Raouf A. Guirguis
-
Patent number: 6194220Abstract: The present invention is directed to non-instrumented assays giving quantitative and/or qualitative results. In one embodiment, the present invention is directed to a process and kit determining analyte in a sample wherein the solid support has a contact zone and binder distributed and immobilized throughout the solid support. A sample and a tracer are added to the contact zone and a visible zone is obtained. In another embodiment, the present invention is directed to a process and test wherein the solid support has two contact zones and the binder is not immobilized on the solid support. In this embodiment, the binder is mobile and is added to the second contact zone. At the same time, sample and a tracer are added to the first contact zone. A visible zone is obtained.Type: GrantFiled: September 25, 1996Date of Patent: February 27, 2001Assignee: Becton, Dickinson and CompanyInventors: Adrien Paul Malick, Edward Charles McFarland
-
Patent number: 6174686Abstract: Assay systems and specialized antibodies for the detection and quantitation of troponin I and troponin T in body fluids as an indicator of myocardial infarction. Since troponin I and T exist in various conformations in the blood, the ratios of the monomeric troponin I an T and the binary and ternary complexes, as well as which form of troponin present in the blood, may be related to the metabolic state of the heart. Disclosed is a system to determine the presence of a troponin form or a group of troponin forms in a sample of whole blood, serum or plasma. Disclosed is a stabilized composition of troponin; the stabilized composition can comprise a stabilized composition of troponin I, wherein the troponin I is oxidized, the troponin I can be unbound or the troponin I can be in a complex.Type: GrantFiled: April 18, 1996Date of Patent: January 16, 2001Assignee: Biosite Diagnostics, Inc.Inventors: Kenneth F. Buechler, Paul H. McPherson
-
Patent number: 6159742Abstract: A carbon-based tip for scanning probe microscopy. The tip used in microscopy to reveal chemical characteristics of a sample includes a structure of the formula:X--(L--M).sub.nin which n is 1 to 100, X is a carbon-based nanotube, L is a linking group bonded at an end of the carbon-based nanotube, and M is a molecular probe bonded to the linking group.Type: GrantFiled: June 4, 1999Date of Patent: December 12, 2000Assignee: President and Fellows of Harvard CollegeInventors: Charles M. Lieber, Stanislaus S. Wong, Adam T. Woolley, Ernesto Joselevich
-
Patent number: 6156179Abstract: The present invention is generally directed to the analysis of biological samples. More particularly, the present invention is directed to automated sample analysis for paraproteins using immunosubtraction, capillary electrophoresis and Fourier transformation analysis.Type: GrantFiled: July 9, 1998Date of Patent: December 5, 2000Assignee: Bio-Rad LaboratoriesInventors: Steven R. Binder, Bryan H. Ikeda, Caroline Scolari
-
Patent number: 6156521Abstract: The invention relates in part to methods and compositions for identifying the presence, measuring the amount, stabilizing, and facilitating recovery of troponin complexes or individual troponin isoforms in a sample.Type: GrantFiled: December 19, 1997Date of Patent: December 5, 2000Assignee: Biosite Diagnostics, Inc.Inventors: Kenneth F. Buechler, Paul H. McPherson
-
Patent number: 6150181Abstract: The invention relates to a process for producing ferrofluid-forming magnetic particles substituted by DMSA (FFSH) that can be covalently coupled, directly or through a difunctional reactant, to an effector, which process comprises combining DMSA with ferrofluid-forming magnetic particles to form FFSS particles having disulfide bonds, and reducing the disulfide bonds of the FFSS at basic pH to form FFSH. The invention includes a composition comprising such FFSH magnetic particles. The invention also relates to a method in which FFSH magnetic particles are incubated with an effector comprising at least one functional group which forms an S--S, C--S, C--C, or C--N bond with DMSA, so that a covalent effector-FFSH complex is formed. The invention further includes a method for separating and/or distinguishing between molecules or cells having a ligand that forms an affinity complex with an effector-FFSH particle of the invention, and those molecules or cells that do not have such a ligand.Type: GrantFiled: June 11, 1998Date of Patent: November 21, 2000Assignee: Universite Pierre et Marie CurieInventors: Avraham Halbreich, Domagoj Sabolovic, Claude Sestier, Danielle Geldwerth, Jean-Noel Pons, Jacky Roger
-
Patent number: 6136611Abstract: An optical assay apparatus is described which includes a light source module and an optical sensing element coupled by an interrogation module. The light source module produces light having propagation angles ranging from a lower, non-zero limit. This is accomplished by including an obscuration which blocks low propagation angle light. The sensing element includes a reflector portion and an sensing fiber portion. The reflector portion receives, as incident light, the light produced by the light source module and produces, as reflected light, light having an approximately constant propagation angle, preferably just less than the critical angle of the sensing fiber. The sensing element also includes a lens position which collimates signal recovery light collected by the sensing fiber. The interrogation module includes a window containing a light source optical fiber that transmits light from the light source module to the sensing element.Type: GrantFiled: July 31, 1997Date of Patent: October 24, 2000Assignee: Research International, Inc.Inventors: Elric W. Saaski, Charles C. Jung
-
Patent number: 6133047Abstract: The superparamagnetic monodispersed particles comprise a core of a first polymer, an internal layer of a second polymer coating the core and in which a magnetic material is distributed, and an external layer of a third polymer coating the magnetic layer and capable of interacting with at least one biological molecule. At least the second polymer is heat sensitive and has a predetermined lower critical solubility temperature (LCST) of 15-65.degree. C. These particles may be used to isolate at least one biological molecule from a liquid specimen.Type: GrantFiled: January 15, 1998Date of Patent: October 17, 2000Assignee: Bio MerieuxInventors: Abdelhamid Elaissari, Christian Pichot, Bernard Mandrand, Florence Sauzedde
-
Patent number: 6121055Abstract: The invention provides methods for separating bound label from unbound label within an assay mixture, for predispensing assay reactants in self-contained assay vessels, as well as for detecting the presence and/or amount of an analyte within a fluid sample. In addition, a reusable detection vessel for use therein and with specific binding assays in general is disclosed. In the methods, generally an analyte within a sample is detected or measured by forming an assay mixture containing sample, analyte binding components and label, placing the assay mixture in contact with an immisable primary layer, subjecting the assay mixture to conditions that separate the analyte bound with binding components and label from unbound binding components and label, and subsequently detecting bound label.Type: GrantFiled: April 28, 1995Date of Patent: September 19, 2000Assignee: Roche Diagnostics CorporationInventor: William R. Hargreaves
-
Patent number: 6066331Abstract: A composition useful for preparing vesicles loaded with biological cell-structures, biopolymers and/or -oligomers is prepared by solubilizing amphiphatic material such as a phospholipid in a polar-protic solvent miscible with water, solubilizing biological cell-structures, biopolymers and/or -oligomers in an aqueous medium, mixing the polar-protic solvent containing the amphiphatic material with the aqueous medium containing the biological cell-structures, biopolymers and/or -oligomers, and lyophilizing the resultant mixture to form a dry product. The dry product is hydrated in an aqueous medium to form the loaded vesicles. The polar-protic solvent may be tert-butanol, and the aqueous medium may contain a salt such as sodium chloride, an isoosmotic cryoprotectant such as lactose, sucrose or trehalose, or a mixture of the salt and the cryoprotectant. A medicament for disease treatment is formed by mixing the loaded vesicles with a pharmaceutically acceptable vehicle.Type: GrantFiled: August 13, 1996Date of Patent: May 23, 2000Inventors: Yechezkel Barenholz, Lilianne K. Bar, Dvorah Diminsky, Moshe Baru
-
Patent number: 6051388Abstract: The present invention relates to bioassay materials useful for the detection of toxic substances and, more particularly, to packaging materials for food and other products, along with methods for their manufacture and use. The invention provides a unique composite material capable of detecting and identifying multiple biological materials within a single package. The biological material identification system is designed for incorporation into existing types of flexible packaging material such as polyolefin films, and its introduction into the existing packaging infrastructure will require little or no change to present systems or procedures.Type: GrantFiled: December 22, 1998Date of Patent: April 18, 2000Assignee: Toxin Alert, Inc.Inventor: William T. Bodenhamer
-
Patent number: 6046056Abstract: The present invention provides novel microfluidic devices and methods that are useful for performing high-throughput screening assays. In particular, the devices and methods of the invention are useful in screening large numbers of different compounds for their effects on a variety of chemical, and preferably, biochemical systems.Type: GrantFiled: December 6, 1996Date of Patent: April 4, 2000Assignee: Caliper Technologies CorporationInventors: J. Wallace Parce, Anne R. Kopf-Sill, Luc J. Bousse
-
Patent number: 6022748Abstract: The present invention relates to methods and compositions for the direct detection of analytes using color changes that occur in immobilized biopolymeric material in response to selective binding of analytes to their surface. In particular, the present invention provides methods and compositions related to the encapsulation of biopolymeric material into metal oxide glass using the sol-gel method.Type: GrantFiled: August 29, 1997Date of Patent: February 8, 2000Assignee: Sandia Corporation - New Mexico Regents of the University of CaliforniaInventors: Deborah H. Charych, Darryl Sasaki, Stacey Yamanaka
-
Patent number: 6020209Abstract: A displacement-type flow immunoassay is performed using a microcapillary sage. The inner wall of the microcapillary passage has immobilized thereon antibodies to the antigen of interest. Labeled antigen is immunologically bound to the immobilized antibodies. Sample antigen passing through the column displaces the labeled antigen. Downstream, the displaced labeled antigen is detected. The microcapillary format of the present invention enhances the sensitivity of the immunoassay over the sensitivity of displacement-type flow immunoassays performed in a column at similar flow rates.Type: GrantFiled: April 28, 1997Date of Patent: February 1, 2000Assignee: The United States of America as represented by the Secretary of the NavyInventors: Upvan Narang, Paul R. Gauger, Frances S. Ligler
-
Patent number: 6017696Abstract: A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats. These reactions include nucleic acid hybridizations, antibody/antigen reactions, diagnostics, and biopolymer synthesis. The device can be fabricated using both microlithographic and micro-machining techniques. The device can electronically control the transport and attachment of specific binding entities to specific micro-locations. The specific binding entities include molecular biological molecules such as nucleic acids and polypeptides. The device can subsequently control the transport and reaction of analytes or reactants at the addressed specific micro-locations. The device is able to concentrate analytes and reactants, remove non-specifically bound molecules, provide stringency control for DNA hybridization reactions, and improve the detection of analytes. The device can be electronically replicated.Type: GrantFiled: July 7, 1994Date of Patent: January 25, 2000Assignee: Nanogen, Inc.Inventor: Michael J. Heller
-
Patent number: 6010854Abstract: A peptide containing 24 amino acid residues that binds to anti-neuronal-glutamate-receptor autoantibodies associated with Rasmussen's encephalitis and that blocks activation of the GluR3 subunit is described. Methods of making the peptide and treating Rasmussen's encephalitis are also disclosed. Autoantibodies to other glutamate receptor subunits are associated with paraneoplastic neurodegenerative disease, amyotrophic lateral sclerosis, and neurodegenerative disease of unknown diagnosis. Methods of screening patients and of monitoring patients being treated for these disorders and syndromes are further described.Type: GrantFiled: July 3, 1997Date of Patent: January 4, 2000Assignee: University of Utah Research FoundationInventors: Scott W. Rogers, Lorise C. Gahring, Roy E. Twyman
-
Patent number: 6001659Abstract: Chemiluminescent electron-rich aryl-substituted 1,2-dioxetane compounds are disclosed in which the aryl group is poly-substituted with suitable electron-donating groups such that the light-emitting pattern of the molecule results in a very high luminescent count, thus providing for a sensitive and precise assay for haptens, analytes, polynucleotides and the like. These substituted aryl-containing 1,2-dioxetane compounds can be used as direct labels in an immunoassay or when derivatized with an appropriate leaving group, can be used as a substrate for a enzyme immunoassay. The unusual chemiluminescence of the compounds allows the timing of the luminescent reaction to be exactly controlled.Type: GrantFiled: May 9, 1995Date of Patent: December 14, 1999Assignee: Abbott LaboratoriesInventors: Nai-Yi Wang, Roger C. Hu
-
Patent number: 5985581Abstract: The invention provides a method of diagnosing Alzheimer's disease. The method utilizes presenilin-1, whose level is found to be substantially decreased in Alzheimer's patients. Included in the invention are diagnostic kits for Alzheimer's disease and methods of screening for effective therapeutics for the disease. The invention also provides a method of studying the function and regulation of presenilin-1 in brain by the use of primate retinoblastoma cells.Type: GrantFiled: July 17, 1997Date of Patent: November 16, 1999Assignee: The McLean Hospital CorporationInventors: Ralph A. Nixon, Anne M. Cataldo, Benjamin H. Kao, Paul M. Mathews
-
Patent number: 5985675Abstract: A test device, system and method, the device composed of an elongated, toothbrush-shaped, transparent, plastic housing and a lateral-flow test strip for the detection of an analyte, such as a beta-lactam in milk, in the housing, the housing having an expansion cavity to receive expanded, liquid-contacted, absorbing material in the test strip, and to control lateral flow rate and times in the test strip.Type: GrantFiled: December 31, 1997Date of Patent: November 16, 1999Assignee: Charm Sciences, Inc.Inventors: Stanley E. Charm, Richard Skiffington, Robert J. Markovsky, Eliezer Zomer
-
Patent number: 5981294Abstract: The invention provides a filter for separating red blood cells from a whole blood sample to form plasma. The filter includes a solid phase support and an agglutinin for red blood cells. The agglutinin is insoluble in the whole blood sample and is immobilized on the solid phase support. The present invention also includes a device and method for determining the presence of at least one of a plurality of analytes in a sample of whole blood.Type: GrantFiled: November 29, 1995Date of Patent: November 9, 1999Assignee: Metrika, Inc.Inventors: Joel M. Blatt, Wilma M. Mangan, Paul J. Patel, Michael P. Allen
-
Patent number: 5981202Abstract: A method for assaying a substance is provided in which an optical image is obtained from spots of light emitted from a chemiluminescent material capable of undergoing a luminescent reaction. The method comprises: (a) a step of distributing solid particles on the surface of a support, the solid particles having a diameter of not more than 100 .mu.Type: GrantFiled: March 3, 1995Date of Patent: November 9, 1999Assignee: Biosensor Laboratories Co., Ltd.Inventor: Masayuki Masuko
-
Patent number: 5976813Abstract: Continuous format high throughput screening (CF-HTS) using at least one porous matrix allows the pharmaceutical industry to simultaneously screen large numbers of chemical entities for a wide range of biological or biochemical activity. In addition, CF-HTS is useful to perform multi-step assays.Type: GrantFiled: December 12, 1997Date of Patent: November 2, 1999Assignee: Abbott LaboratoriesInventors: Bruce A. Beutel, Mark E. Schurdak, Martin J. Voorbach, David J. Burns, Mary K. Joseph
-
Patent number: 5968729Abstract: A method is provided using centrifugation to prepare a seal of solidified wax, grease or polymer mix over an aqueous reagent in a reaction container such that the reagent is separated from contact with the atmosphere. The amount of solidified wax, grease or polymer mix is not sufficient when melted to a liquid to separate the reagent from contact with the atmosphere under gravity. A reagent and solidified wax, grease or polymer mix are combined in a container. During centrifugation and heating, the solidified wax, grease or polymer mix melts to a liquid, and centrifuging causes the liquid to form over the reagent a layer that completely separates the reagent from the atmosphere. As centrifugation continues, the liquid is cooled and solidified to form the seal. Additional reagents are preferably added on top of the seal such that when the container is heated and the seal melted the upper and lower reagents mix for reaction.Type: GrantFiled: March 28, 1998Date of Patent: October 19, 1999Inventors: Kenneth M. Kosak, Matthew K. Kosak
-
Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials
Patent number: 5965454Abstract: There is disclosed an automated apparatus, reagents and process for immunocytochemical staining of biological materials using ligand pairing. The present invention provides a method for storing a ligand in a macroscopic solid support and releasing the ligand into contact with a biological sample mounted on a surface of a substrate. The process includes providing a macroscopic solid support formed of a solidified matrix material encapsulating a ligand therein with the macroscopic solid support being disintegratable to release the ligand therefrom. The solid support is placed in a first chamber which is in flow communication with a second chamber containing the substrate with the biological sample affixed thereto. The step of disintegrating the macroscopic solid support may include heating the macroscopic solid support to liquefy it when the matrix material is gelatin or a wax.Type: GrantFiled: May 5, 1997Date of Patent: October 12, 1999Assignee: Histaggen IncorporatedInventors: A. James Farmilo, Ronald H. Stead -
Patent number: 5958345Abstract: A sample support for holding for samples for use with an analysis instrument. The sample support is particularly beneficial for use with analysis instruments which rely on a beam of radiation or accelerated particles and a method for making the same is disclosed. The holder includes a frame with one or more orifices covered by a support surface, typically in the form of a thin polymer film. The film is divided into hydrophobic and hydrophilic portions to isolate precise positions where samples can be placed to intersect a probe beam during analysis.Type: GrantFiled: March 14, 1997Date of Patent: September 28, 1999Assignee: Moxtek, Inc.Inventors: D. Clark Turner, Arthur A. Robbins, Alisa A. Wilson
-
Patent number: 5942442Abstract: Apparatus and method for detection of low levels of about 1 ppb of analyte in samples using an enclosed permeable membrane enrichment device and agglutination reaction slide test apparatus.Type: GrantFiled: April 2, 1997Date of Patent: August 24, 1999Assignees: The Perkin-Elmer Corporation, Roche Dianostic Systems, Inc.Inventors: Joseph L. Di Cesare, Steven M. Rosen
-
Patent number: 5939331Abstract: A method and device for detecting the presence, absence or amount of an analyte in a whole blood sample is disclosed. The device comprises four zones, a sample receiving zone, a labeling zone, a capture zone and an absorbent zone. The sample receiving zone contains an irreversibly immobilized reagent that allows for removal of substantially all red blood cells from the whole blood sample. Flow through the device is via capillary migration and all of the dissolved or dispersed components in the sample flow at substantially equal rates and with relatively unimpaired flow through the device. The method involves the use of the device for detection of analyte in a whole blood sample.Type: GrantFiled: May 21, 1993Date of Patent: August 17, 1999Assignee: Quidel CorporationInventors: John Burd, Steven Miller, Gerald Rowley, Allan Pronovost
-
Patent number: 5928957Abstract: Starting from two non-miscible phases, i.e., a lipophilic and a hydrophilic phase, a surface-active substance and a recognition component, a micellar recognition system is built in a suitable manner and is incorporated into a layer structure. The micellar recognition system is provided in a single thin layer in which the recognition component is distributed homogeneously. Additional layers which may be provided about this layer, have an influence on the properties of the entire layer structure. On contact between the layer structure and the substance to be measured a recognition step takes place in the layer which is followed by a transducing step. In this way a measurement variable is produced by means of which information is obtained on the substance. The layer structures exhibit higher sensitivity, a lower detection threshold, short response time and special robustness with regard to sample interference.Type: GrantFiled: October 24, 1995Date of Patent: July 27, 1999Assignee: AVL Medical Instruments AGInventors: Ursula Spichiger-Keller, Eva Vaillo
-
Patent number: 5922615Abstract: Devices for use in heterogeneous ligand-receptor assays, having a porous member in contact with a nonabsorbent textured surface, where the surface texturing is such that a capillary network is formed when in fluid communication with the porous member. More particularly, these devices comprise:(a) a porous member having (i) at least one binding agent capable of immobilizing at least one target ligand on the porous member from a fluid sample in at least one zone and (ii) a means for detecting the presence or amount of said target ligand as a result of the assay process; and(b) a nonabsorbent member in fluid communication with the porous member, the nonabsorbent member forming at least one capillary with the porous member so that when sample, alone or in combination with other fluids, is added to the porous member, fluid is drawn through the porous member.Type: GrantFiled: June 2, 1995Date of Patent: July 13, 1999Assignee: Biosite Diagnostics IncorporatedInventors: Mark R. Nowakowski, Kenneth F. Buechler, Richard R. Anderson, Gunars E. Valkirs
-
Patent number: 5922533Abstract: A method of performing a rapid assay for the simultaneous detection and differentiation of the analytes HIV-1 group M. HIV-1 group O and HIV-2 utilizing a sequence specific polypeptide of each analyte as capture reagents. An analytical. device also is provided for performing the method which includes these capture reagents. Also provided is a test kit which includes the analytical device which further can include a positive and negative control.Type: GrantFiled: August 15, 1997Date of Patent: July 13, 1999Assignee: Abbott LaboratoriesInventors: Anadruzela S. Vallari, John R. Hackett, Jr., Robert K. Hickman, Vincent A. Varitek, Jr., Elizabeth C. Necklaws, Alan M. Golden, Catherine A. Brennan, Sushil G. Devare
-
Patent number: 5912116Abstract: The present invention includes novel barrier webs that have certain desirable physical qualities such as water resistance, increased durability, improved barrier qualities and the like. The present invention further comprises a barrier web comprising a web that has been treated with a curable shear thinned thixotropic polymer composition, the fabric being adapted to be substantially impermeable to liquids, permeable to gases and impermeable to microorganisms. The barrier webs of the present invention are either impermeable to all microorganisms or are impermeable to microorganisms of certain sizes. The present invention also includes fabrics that are capable of either selective binding certain microorganisms, particles or molecules depending upon what binding partners are incorporated into the polymer before application to the fabric.Type: GrantFiled: June 7, 1995Date of Patent: June 15, 1999Assignee: Nextec Applications, Inc.Inventor: J. Michael Caldwell
-
Patent number: 5886104Abstract: A solid support for the solid-phase synthesis of peptides or proteins in high yield and in high purity, suited both to the synthesis of a single peptide or protein and to the parallel and substantially simultaneous synthesis of a plurality thereof, is based on a cross-linked polyolefin, especially polyethylene, substrate, the cross-linking having been obtained by irradiation with high energy electrons or .gamma. radiation or treatment with organic peroxide such as benzoyl peroxide, to which substrate are grafted polymer chains such as polystyrene chains which are functionalized with a chemical functionality facilitating the formation of an anchoring linkage between the polymer moiety and another chemical species. The solid support is also suited for use in solid-phase biosystems, notably bioassays, such as immunoassays, DNA hybridization assays or PCR amplification.Type: GrantFiled: December 18, 1995Date of Patent: March 23, 1999Assignee: Forskniingscenter RisoInventors: Walther Batsberg Pedersen, Kristoffer Almdal, Lars Winther, Rolf Henrik Berg
-
Patent number: 5866434Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called "buckytubes") and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.Type: GrantFiled: March 6, 1996Date of Patent: February 2, 1999Assignee: Meso Scale TechnologyInventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
-
Patent number: 5854078Abstract: Novel sensor devices composed of a crystalline colloidal array (CCA) polymerized in a hydrogel are disclosed. The hydrogels are characterized as being capable of shrinking and swelling in response to specific stimuli applied thereto. As the hydrogels shrink or swell, the lattice structure of the CCA embedded therein changes, thereby changing the wavelength of light diffracted by the CCA. Thus by monitoring the change in diffracted wavelength, the concentration of a stimulus is determined. The gels can be modified to sense numerous different stimuli. The sensor devices are specific in that they are modified to react with only one species or family of species. These sensors have various applications in areas including, for example, environmental and chemical systems, chemomechanical systems, sensor devices and medical diagnostic tools. Various methods for making and using these devices are also disclosed.Type: GrantFiled: March 17, 1997Date of Patent: December 29, 1998Assignee: University of PittsburghInventors: Sanford A. Asher, John H. Holtz
-
Patent number: 5846745Abstract: A method and test device are disclosed for detecting under field conditions unidentified antigenic substances which are detrimental to human or animal health or welfare. A sample solution containing the suspected unidentified antigenic substance is added to the test device containing a known antigenic substance which is irreversibly attached to a solid support and suspended in a buffer solution along with an antibody specific to the known antigenic substance conjugated with a detecting agent. After incubation to bind the unknown antigenic substance to the conjugate, the solution contacts a white porous bibulous sheet incorporating a substrate for the detecting agent and a chromogen, which is part of the test device. If the identity of the sample antigen is the same as that on the solid support, a color reaction takes place.Type: GrantFiled: September 3, 1996Date of Patent: December 8, 1998Assignee: Camas Diagnostic CompanyInventors: Dale A. Christensen, Peter Nash
-
Patent number: 5846843Abstract: A long range surface plasmon resonance sensor for use in biological, biochemical or chemical testing. The sensor includes a first dielectric medium and a second dielectric medium having an index of refraction approximately matching the first dielectric medium. A double-grating structure is located between the first dielectric medium and the second dielectric medium. A beam of electromagnetic radiation is introduced into the second dielectric medium in a manner which causes long range surface plasmon resonance to occur such that the beam of radiation suffers attenuated total reflection. The characteristics of the resonance dependent upon the reaction between the bonding layer and the targeted bonding molecule are then detected.Type: GrantFiled: November 18, 1996Date of Patent: December 8, 1998Assignee: The University of ToledoInventor: Henry John Simon
-
Patent number: 5827749Abstract: Methods for determining the presence of a ligand in a sample suspected to contain the ligand are provided, along with apparatus suitable for performing the methods. The methods depend upon a color visualization indicating the ligand's presence or absence in the sample. Preferred methods comprise contacting the sample with colored particles which bear on their surface a receptor specific for the ligand, passing the sample/particle mixture through a filter, and then analyzing the color of the filtrate. The presence of ligand in the sample is established where the color of the filtrate is substantially different from the color of the receptor-bearing particles.Type: GrantFiled: October 11, 1996Date of Patent: October 27, 1998Assignee: Akers Laboratories, Inc.Inventor: Raymond F. Akers, Jr.
-
Patent number: 5820873Abstract: The present invention provides a novel class of polyethylene glycol modified ceramide lipids. The lipids can be used to form liposomes optionally containing various biological agents or drugs, such as anti-cancer agents. In addition, methods of use for the liposomes are provided.Type: GrantFiled: June 7, 1995Date of Patent: October 13, 1998Assignee: The University of British ColumbiaInventors: Lewis S. L. Choi, Thomas D. Madden, Murray S. Webb
-
Patent number: 5811312Abstract: An optical measurement apparatus includes a reaction vessel 2 which is formed in one body with a slab-type optical waveguide 1, and the apparatus adds fine-grains or water soluble dye for absorbing a fluorescent light which is radiated from fluorescent dye, and/or an exciting light so that stray light due to reagent is reduced and the S/N ratio of the optical measurement is improved.Type: GrantFiled: August 30, 1995Date of Patent: September 22, 1998Assignee: Daikin Industries, Ltd.Inventors: Masanori Hasegawa, Tomoaki Ueda, Kazuhisa Shigemori, Kenji Masuda, Masakazu Yoshida, Tomomi Sakamoto
-
Patent number: 5807757Abstract: A method is provided for preparing polyphosphazene microspheres wherein the polyphosphazene microspheres are produced by coacervation. A solution containing a polyphosphazene is admixed with a solution containing a salt of a monovalent ion such as a salt of a Group I element (for example, NaCl) to form a dispersion containing polyphosphazene coacervate microdroplets. The dispersion then is admixed with a solution containing a salt of a multivalent ion, such as a salt of a Group II element (for example, CaCl.sub.2) to form a suspension of polyphosphazene microspheres. The polyphosphazene microspheres then are recovered from the suspension. Such method enables one to obtain high yields of microspheres having a controlled size distribution. Polyphosphazene microspheres containing biological material can be produced by providing a biological material in the polyphosphazene solution that is mixed with the solution containing a salt of a monovalent ion.Type: GrantFiled: July 2, 1996Date of Patent: September 15, 1998Assignee: Virus Research Institute, Inc.Inventors: Alexander K. Andrianov, Jianping Chen
-
Patent number: 5795725Abstract: Assays and antibodies are disclosed for the detection and quantitation of cardiac specific troponin I and troponin T in body fluids as an indicator of myocardial infarction. Since troponin I and T exist in various conformations in the blood, the ratios of the monomeric troponin I and T and the binary and ternary complexes may be related to the metabolic state of the heart. More specifically, immunoassays for determining the presence or amount of free, binary and ternary complexes of troponin I and T are claimed.Type: GrantFiled: April 18, 1995Date of Patent: August 18, 1998Assignee: Biosite Diagnostics IncorporatedInventors: Kenneth F. Buechler, Paul H. McPherson